Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2009
09/17/2009US20090233304 diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome; biomarker consisting of between 3 and 35 different nucleic acid probe sets
09/17/2009US20090233303 Methods for assessing breakdown products and stability of sirna and other target oligonucleotides
09/17/2009US20090233302 Labeled reactants and their uses
09/17/2009US20090233301 In Vitro System for Assessing Immune Activity Using Pig Immune Cells
09/17/2009US20090233300 Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto
09/17/2009US20090233299 Physiogenomic Method for Predicting Statin Injury to Muscle and Muscle Side Effects
09/17/2009US20090233298 Fig4 gene mutations in neurodegeneration
09/17/2009US20090233297 Microrna markers for recurrence of colorectal cancer
09/17/2009US20090233296 Thiamin production by fermentation
09/17/2009US20090233295 Trim59 directed diagnostics for neoplastic disease
09/17/2009US20090233294 Uhrf1 directed diagnostics for neoplastic disease
09/17/2009US20090233293 Ttk directed diagnostics for neoplastic disease
09/17/2009US20090233292 Method and kit for identification of genetic polymorphisms
09/17/2009US20090233291 genomic sequencing; a library may be constructed in vitro without the use of prokaryotic or eukaryotic host cells
09/17/2009US20090233290 Mutant SepRS, and method for site-specific introduction of phosphoserine into protein using the same
09/17/2009US20090233289 Novel DNA threading intercalators
09/17/2009US20090233288 Primer set for gene amplification, reagent for gene amplification including the same, and uses thereof
09/17/2009US20090233287 Production of compounds in a recombinant host
09/17/2009US20090233286 Methods of diagnosis and prognosis of pancreatic cancer
09/17/2009US20090233285 Specific method of prostate cancer detection based on pca3 gene, and kits therefor
09/17/2009US20090233284 Method for the simultaneous detection of mutations occurring in related genomes, exploiting mobility variations in 2-d electrophoresis of dna duplexes undergoing differential helix-coil transition in a denaturing gradient
09/17/2009US20090233283 Stable compositions for nucleic acid amplification and sequencing
09/17/2009US20090233282 Probe, probe set, probe carrier, and testing method
09/17/2009US20090233281 Diagnostic marker for allergy
09/17/2009US20090233280 Method of acquiring information regarding base sequence and information reading device for the same
09/17/2009US20090233279 Methods and Compositions for Predicting Death from Cancer and Prostate Cancer Survival Using Gene Expression Signatures
09/17/2009US20090233278 Branched-chain amino acid aminotransferase gene and use thereof
09/17/2009US20090233277 Primer generation rolling circle amplification
09/17/2009US20090233276 Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
09/17/2009US20090233275 Eotaxin-3 in eosinophilic esophagitis
09/17/2009US20090233274 Drug development target protein and target gene, and method of screening
09/17/2009US20090233273 Transgenic aloe plants for production of proteins and related methods
09/17/2009US20090233272 Multiplexed Nucleic Acid Analysis with High Specificity
09/17/2009US20090233271 Species-Specific And Quantitative Detection Of CNS Tissue In Meat And Meat Products
09/17/2009US20090233270 Secreted and cytoplasmic tumor endothelial markers
09/17/2009US20090233269 Detection of a Target in a Preservative Solution
09/17/2009US20090233268 Detection of biomarkers and biomarker complexes
09/17/2009US20090233267 Methylated Tat Polypeptides and Methods of Use Thereof
09/17/2009US20090233266 Structure of the hepatitis c virus ns2 protein
09/17/2009US20090232910 Biomarkers and therapeutics targets for cognitive decline
09/17/2009US20090232893 miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
09/17/2009US20090232848 Methods for cultivating lawsonia intracellularis
09/17/2009US20090232843 Identifying and predicting influenza variants and uses thereof
09/17/2009US20090232831 Methods and compositions for the treatment or prevention of human immunodeficiency virus infection
09/17/2009US20090232827 Compositions and methods of use of compounds to increase cancer patient survival time
09/17/2009US20090232821 Use Of A Growth-Stimulating Protein
09/17/2009US20090232820 Neisseria meningitidis antigens and compositions
09/17/2009US20090232819 Method using snail transcriptional repressor
09/17/2009US20090232814 Cancer biomarker genes and gene products and methods for using the same
09/17/2009US20090232813 Four-Jointed Box (FJX1) In Cancer Diagnosis and Treatment
09/17/2009US20090232812 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
09/17/2009US20090232809 Type 2 cytokine receptor and nucleic acids encoding same
09/17/2009US20090232802 Compositions and methods for the treatment of natural killer cell related diseases
09/17/2009US20090232800 E1-minus adenoviruses and use thereof
09/17/2009US20090232779 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
09/17/2009US20090232778 Methods and Compositions for Hair Growth
09/17/2009US20090232777 Expansion and Differentiation of Mesenchymal Stem Cells
09/17/2009US20090232773 Method for Distinguishing Mesenchymal Stem Cell Using Molecular Marker and Use Thereof
09/17/2009US20090232771 Method of controlling cell functions
09/17/2009US20090232742 Method for screening agent with angiogenic-modulating activities using teleost embryo
09/17/2009US20090232738 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity
09/17/2009US20090230300 Rapid detection of volatile organic compounds for identification of bacteria in a sample
09/17/2009US20090229179 Method of Land Management Involving Microbial Bioassay
09/17/2009DE10350474C5 Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen A method of selecting variants of biomolecules from libraries of biomolecules
09/17/2009DE102008014029A1 Determining microbial contamination of water, comprises supplying sample in a reaction chamber, adding determined quantity of nutrient solution, which is a minimal medium, and intermixing the mixture of nutrient solution and water sample
09/17/2009DE102005049800B4 Verfahren zur Auffindung von Inhibitoren des Epstein-Barr-Virus-induzierten Gens 3 (EBI 3) und deren Verwendungen bei der Behandlung von metastasierenden Tumoren und allergischem Asthma A method for identifying inhibitors of the Epstein-Barr virus induced gene 3 (EBI 3) and their uses in the treatment of metastatic tumors and allergic asthma
09/17/2009CA2722479A1 Rna-selective hybridization reagent and use of the same
09/17/2009CA2718404A1 Labeled reactants and their uses
09/17/2009CA2718392A1 Biomarkers for alzheimer's disease
09/17/2009CA2718382A1 C2orf18 as target gene for cancer therapy and diagnosis
09/17/2009CA2718293A1 Dna repair proteins associated with triple negative breast cancers and methods of use thereof
09/17/2009CA2718276A1 Enzymatic substrates for multiple detection systems
09/17/2009CA2718059A1 Assays for diagnosing and evaluating treatment options for pompe disease
09/17/2009CA2718032A1 Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications
09/17/2009CA2717994A1 Target amplification and sequencing with primers comprising triplex forming monomer units
09/17/2009CA2717340A1 Method of denaturing protein with enzymes
09/17/2009CA2717320A1 Nucleic acid-based tests for prenatal gender determination
09/17/2009CA2717197A1 Disease model incorporation into an artificial immune system (ais)
09/17/2009CA2715319A1 Genetic variations associated with drug resistance
09/17/2009CA2710807A1 Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
09/17/2009CA2658074A1 Functional pigmented skin equivalent
09/16/2009EP2100971A2 Real-time sequence determination
09/16/2009EP2100970A2 Ig genes specific oligonucleotides and uses thereof
09/16/2009EP2100969A1 Rapid method for identifying polypeptide-nucleic acid interactions
09/16/2009EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents
09/16/2009EP2100958A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
09/16/2009EP2100617A1 Methods of modulating CD200 receptors
09/16/2009EP2100507A1 Substance capable of inhibiting cytokinin signaling
09/16/2009EP2100129A1 Sensor device
09/16/2009EP2099938A1 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
09/16/2009EP2099937A2 Genetic susceptibility variants of type 2 diabetes mellitus
09/16/2009EP2099936A1 Improved multiplex nucleic acid amplification using blocked primers
09/16/2009EP2099935A2 Array for detecting microbes
09/16/2009EP2099934A2 Detection and quantification of biomolecules using mass spectrometry
09/16/2009EP2099933A2 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
09/16/2009EP2099932A2 Nucleic acids encoding recombinant protein a
09/16/2009EP2099931A2 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of a subject
09/16/2009EP2099930A2 Systems and methods for multiplex analysis of pcr in real time
09/16/2009EP2099929A2 Cancer-linked genes as biomarkers to monitor response to impdh inhibitors
09/16/2009EP2099928A2 Two-stage nucleic acid amplification using an amplification oligomer